Replies to post #205002 on Avid Bioservices Inc (CDMO)

[Protector]

I don't think they'll go for compassionate use. I already made that point once long ago.

Once they start using the content of the patent, under WHATEVER LABEL or STATUS, and it brings revenue or could be seen as promotional or any other of the activities the patent gives them protection for, there will be a date attached to that.

So at patent expiration time that will at some point come up when the patent must be extended and they file a request. If the extension is max. 7 years then and since the patent is more then 7 years old it may not play, but I am not sure of that.

Furthermore, given the dose switching incident PPHM will create NO situation they can avoid that could go wrong out of their control.

So I would say that there is little chance for passionate use. Now, of course it is PPHM, if they ever would get a request - and I doubt that because almost nobody know they even exit, are the ones to decide.

I think AA at first look-in ? I don't know. Maybe, maybe not. They must file for it and I think there must be unbinding. So that would mean the trial should be stopped (not just look-in). Not sure, I kind of forgot the procedure.